Navigation Links
Hepregen Corporation Receives SBIR Phase II Grant from the National Science Foundation and Presents Corporate Update at OneMed Forum
Date:1/13/2010

New Grant Adds to Hepregen’s Previous NIH Funding and Continued Development of the Company’s Platform for Advanced Toxicity Screening and Drug Discovery

San Francisco, CA and Medford, MA (Vocus) January 13, 2010 -- Hepregen Corporation, a leading provider of bioengineered solutions for drug development, announced today that it has received a Phase II SBIR grant from the National Science Foundation for $500,000. This latest award, in addition to the company’s receipt of a prestigious Challenge Grant from the National Institutes of Health (NIH), along with earlier grant awards, approaches $2.0M in federal funding.

Hepregen will also be a featured speaker this afternoon at OneMedForum, where CEO Bernadette (Bonnie) Fendrock will highlight the company’s successful progress since its Series A financing in 2008 from Battelle Ventures, as well as outline important milestones for 2010 and beyond.

The SBIR Phase II grant received from the National Science Foundation will support Hepregen’s project, "Development of a Human Liver Platform for High-Throughput Screening of Drug-Induced Liver Injury and Drug-Drug Interaction.” The project is currently being lead by Dr. Salman Khetani, co-developer of Hepregen’s platform technology and also Director of Research at the company. The grant, which initiates on January 15, 2010, as well as the previous Challenge grant from the NIH, will be contributors to the company’s growth as Hepregen continues to develop its proprietary HepatoPaC™ technology.    

Hepregen President and CEO Bonnie Fendrock, who cofounded the company, commented, “2009 was an exciting year at the company. With the Series A financing from Battelle Ventures in combination with our grant funding, Hepregen was able to execute on its business plan. Liver toxicity is a leading cause o
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. United American Healthcare Corporation Announces Meeting Date and Record Date for Annual Meeting of Shareholders
2. Amerigroup Corporation to Discuss Fourth Quarter and 2009 Year-End Earnings on February 19
3. Providence Service Corporation Comments on Senate Health Care Reform
4. Triple-S Management Corporation to Present at J. P. Morgan Healthcare Conference
5. Service Corporation International Extends Offer for Keystone North America Inc.
6. Atrion Networking Corporation Selects Ruckus Wireless for Reliable as Wire Enterprise Wi-Fi Service
7. Corporations, Universities and State Governments Deploy Thomson Reuters Solution to Improve Employees Benefit Selection Process
8. China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009
9. New Board Gains Control of U.S. Shanghai Chemical Corporation
10. Centene Corporation to Provide 2010 Financial Guidance On January 8, 2010
11. American Diversified Holdings Corporation Announces Stem Cell Patent Acquisition Program
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hepregen Corporation Receives SBIR Phase II Grant from the National Science Foundation and Presents Corporate Update  at OneMed Forum
(Date:4/18/2014)... Harvard neuroscientists have made a discovery that turns 160 ... electrical insulating material long known to be essential for ... nerve cells, is not as ubiquitous as thought, according ... of the Harvard Stem Cell Institute (HSCI) and the ... collaboration with Professor Jeff Lichtman, of Harvard,s Department of ...
(Date:4/18/2014)... (April 18, 2014) ― A new study in the ... patterns in health-related Google searches reveals a recurring pattern ... , Investigators from San Diego State University, ... Monday Campaigns, analyzed "healthy" Google searches (searches that included ... diet") originating in the U.S. from 2005 to 2012. ...
(Date:4/17/2014)... genetic variant specifically associated with the risk of ... per cent of all breast cancer cases. , ... sub-type, called invasive lobular carcinoma, gives researchers important ... kind of breast cancer, which can be missed ... in the journal PloS Genetics , was ...
(Date:4/17/2014)... Researchers at the University of California, San Diego School ... those who have suffered a recent major loss are ... older adults. , The study is published in this ... Psychiatry . , Because compassionate behaviors are associated with ... findings offer insights into ways to improve the outcomes ...
(Date:4/17/2014)... personnel who served in Iraq and Afghanistan and ... (TBI) were compared to military personnel without TBI ... in measures of overall disability, cognitive function, post-traumatic ... reported in an article in Journal of ... Liebert, Inc., publishers. The article is available free ...
Breaking Medicine News(10 mins):Health News:Finding turns neuroanatomy on its head 2Health News:Finding turns neuroanatomy on its head 3Health News:New research shows people are thinking about their health early in the week 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:The ilk of human kindness 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2
... pulmonary embolisma potential life-threatening blockage in a lung arteryshould ... than a CT (computed tomography) angiogram, conclude authors in ... Medicine. , A V/Q scan can be the first ... a pulmonary embolism, noted H. Dirk Sostman, a professor ...
... health care, the SNM Technologist Section recently revised ... Technologist 2007. The updated, forward-looking scopewith its primary ... evolving nature of technology and scienceclearly defines a ... and molecular imaging. , Scope of practice ...
... be compromised by new provisions enabling commercial companies to ... , A study, led by the Centre for International ... that, as a result of changes to how ... to provide patients with integrated and comprehensive services. , ...
... Sept. 7 A new gift line of 19,aromatherapy ... and,Chill Out(TM) has been introduced by Aromatherapy Interventions(TM), a,Newport ... serious aromacology, the science of scent,",says John McKee, CEO, ... Citing Frankincense as an example, McKee notes the scent ...
... Strong Revenue Growth, Driven by Growing Demand for ... Corporate Performers, CHICAGO, Sept. 7 Allscripts ... software, connectivity and information,solutions that physicians use to ... of FORTUNE magazine,s 100 Fastest-Growing Companies for,2007. The ...
... Anthem Blue Cross and Blue Shield in Indiana for ... (NYSE: WLP ) and,M-Plan, Inc., an Indiana-based managed ... Cross and Blue Shield of Indiana as,the insurer of ... exits the,commercial HMO business. WellPoint and M-Plan have entered ...
Cached Medicine News:Health News:Nuclear medicine approach can be first choice for excluding pulmonary embolism in young women 2Health News:Medical, technological advances prompt updating of nuclear medicine technologists' scope of practice 2Health News:Medical, technological advances prompt updating of nuclear medicine technologists' scope of practice 3Health News:Care reforms raise concerns over patient access to GP services 2Health News:Allscripts Named to FORTUNE 100 Fastest-Growing Companies List 2Health News:Allscripts Named to FORTUNE 100 Fastest-Growing Companies List 3Health News:WellPoint and M-Plan Enter Into Endorsement Agreement as M-Plan Announces Exit From the Commercial HMO Business in Indiana 2Health News:WellPoint and M-Plan Enter Into Endorsement Agreement as M-Plan Announces Exit From the Commercial HMO Business in Indiana 3
(Date:1/15/2014)... , Jan. 15, 2014  According to Millennium Research ... market intelligence, the United States ... device markets will expand moderately through 2022, with ... In particular, increasing interest in drug-eluting beads (DEBs) ...
(Date:1/15/2014)... , Jan. 15, 2014 ... research report is available in its ... Markets and Technologies for Advanced Drug ... of Administration ...
(Date:1/14/2014)... , Jan. 14, 2014 InformEx, North ... sellers of high-value chemistry, will hold the 30 th ... Beach Convention Center from January 21-24. ... attendees from top pharmaceutical, fine chemical and specialty chemical companies ...
Breaking Medicine Technology:US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
... 2011 /PRNewswire-Asia-FirstCall/ -- DK Sinopharma, Inc. (OTC Bulletin Board: ... that it will present at the Rodman & Renshaw Annual ... the Le Royal Meridien Shanghai in Shanghai, China. ... present on behalf of the Company on Tuesday, March 8, ...
... AORN Works , a subsidiary of the ... market research and surgical insights division will lead the ... http://photos.prnewswire.com/prnh/20101001/DC75398LOGO ) On behalf of ... professionals who are the end users of medical products ...
Cached Medicine Technology:DK Sinopharma, Inc. is to Present at the Rodman & Renshaw Annual China Investment Conference to be Held March 6--8 2Advanced Market Research for Medical Device Manufacturers 2
... Severe revision options for the knee and ... modular system for the knee and hip ... that include surgical indication, implant selection, connection ... individual needs. This system addresses the needs ...
The Advance stemmed medial-pivot knee is a revision knee that provides unique and competitive features....
... The NexGen CRA femoral component ... adequate mediolateral, anteroposterior, and varus/valgus ligament ... extensions due to inadequate bone stock. ... available with a PMMA precoat surface. ...
... System will define the state of knee ... less - reducing inventory requirements and increasing ... and cost situations. The GENESIS II ... surgeons creative solutions tomeet todays surgical demands. ...
Medicine Products: